Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Journal article
Tomic A. et al, (2022), Nature Communications, 13
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
Journal article
Donovan-Banfield I. et al, (2022), Nat Commun, 13
An introduction to the Marburg virus vaccine consortium, MARVAC.
Journal article
Cross RW. et al, (2022), PLoS pathogens, 18
Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.
Journal article
Rottstegge M. et al, (2022), Journal of virology
Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model.
Journal article
Wing PAC. et al, (2022), PLoS pathogens, 18
A prototype lateral flow assay for detection of orthopoxviruses.
Journal article
Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
Journal article
McNaughton AL. et al, (2022), JCI Insight, 7
Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.
Journal article
Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
Journal article
Shankar S. et al, (2022), Journal of the American Society of Nephrology, 33, 883 - 887
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.
Journal article
Guimond SE. et al, (2022), ACS central science, 8, 527 - 545
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
Journal article
Salam AP. et al, (2022), PLOS Neglected Tropical Diseases, 16, e0010289 - e0010289
Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.
Journal article
Gray-Rodriguez S. et al, (2022), The Journal of pathology
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers
Journal article
Dong X. et al, (2022), GigaScience, 11
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.
Journal article
Mellors J. et al, (2022), Frontiers in immunology, 13
Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera.
Journal article
Belij-Rammerstorfer S. et al, (2022), Frontiers in veterinary science, 9
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals.
Journal article
Longet S. et al, (2022), Frontiers in immunology, 13
The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae.
Journal article
Vanmechelen B. et al, (2022), Virus evolution, 8
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.
Journal article
Gartlan C. et al, (2022), Frontiers in immunology, 13
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Journal article
Tan TK. et al, (2021), Nature Communications, 12
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
Journal article
Lambe T. et al, (2021), Communications Biology, 4
Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic
Journal article
Tipton TRW. et al, (2021), Nature Communications, 12
Quantification of type i interferon inhibition by viral proteins: Ebola virus as a case study
Journal article
Locke M. et al, (2021), Viruses, 13
Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
Journal article
Marriott AC. et al, (2021), npj Vaccines, 6
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
Journal article
Skelly DT. et al, (2021), Nature Communications, 12
Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.
Journal article
Watson RJ. et al, (2021), Journal of virology, 95
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Journal article
Payne RP. et al, (2021), Cell, 184, 5699 - 5714.e11
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.
Journal article
Huo J. et al, (2021), Nature communications, 12
Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application.
Journal article
Hargreaves A. et al, (2021), Pathogens (Basel, Switzerland), 10
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.
Journal article
Keita AK. et al, (2021), Nature, 597, 539 - 543
Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
Journal article
Bewley KR. et al, (2021), Science Advances, 7
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS.
Journal article
Aljabr W. et al, (2021), mSphere, 6
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies.
Journal article
van Haren FMP. et al, (2021), British journal of clinical pharmacology, 87, 3075 - 3091
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
Journal article
Gooch KE. et al, (2021), Vaccine, 39, 4885 - 4894
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Journal article
Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13
Metagenomic identification of a new sarbecovirus from horseshoe bats in Europe.
Journal article
Crook JM. et al, (2021), Scientific reports, 11
Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission, United Kingdom, 2018/19 influenza season
Journal article
Xu Y. et al, (2021), Eurosurveillance, 26
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article
Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article
Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.
Journal article
Bewley KR. et al, (2021), Nature protocols, 16, 3114 - 3140
Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore Sequencing
Journal article
Peto L. et al, (2021), Journal of Clinical Microbiology, 59
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
Preprint
McNaughton AL. et al, (2021)
Antibody evasion by the P.1 strain of SARS-CoV-2
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9
T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study
Journal article
Angyal A. et al, (2021), SSRN Electronic Journal
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Journal article
Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
Journal article
Thom R. et al, (2021), The Lancet Infectious Diseases, 21, 507 - 516
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Journal article
Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22